Evoke Wealth’s Clover Health Investments CLOV Stock Holding History

Evoke Wealth’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33	Closed	–	–	509
2022 Q3	$0	Hold	33	–	–	﹤0.01%	1186
2022 Q2	$0	Buy	+33	New	+$88	﹤0.01%	1185

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Evoke Wealth's CLOV Position: Q4 2022 in Review

Evoke Wealth sold out of Clover Health Investments (CLOV) in Q4 2022, closing a stake of 33 shares.

Evoke Wealth first reported a position in CLOV in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 175 funds tracked by Wall St. Rank hold CLOV as of Q4 2022.

Evoke Wealth reported no remaining Clover Health Investments position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 33 Clover Health Investments shares in Q4 2022.
Evoke Wealth first reported a position in Clover Health Investments in Q2 2022 and held it in 2 quarters.
Evoke Wealth's Clover Health Investments position peaked at $0 in Q3 2022.
175 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.